High levels of transduction of human dendritic cells with optimized SIV vectors

Molecular Therapy

Volumn 5, Issue 3, 2002, Pages 283-290

  Mangeot, Philippe Emmanuel ^a   Duperrier, Karine ^b   Nègre, Didier ^a   Boson, Bertrand ^a   Rigal, Dominique ^b   Cosset, François Loïc ^a   Darlix, Jean Luc ^a  

^a UNIVERSITÉ DE LYON   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Dendritic cells; Gene therapy; Gene transfer; Lentiviral vectors; Lentiviruses; Monocytes; SIV; Vpx

Indexed keywords

GAG PROTEIN; LENTIVIRUS VECTOR; PHOSPHOGLYCERATE KINASE; POL PROTEIN; REGULATOR PROTEIN; REV PROTEIN; TRANSACTIVATOR PROTEIN;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DENDRITIC CELL; GENE EXPRESSION; GENE INSERTION; GENE SEQUENCE; GENE TARGETING; GENE TRANSFER; HEPATITIS VIRUS; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE REACTION; MONOCYTE; PROMOTER REGION; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE;

INSERTION SEQUENCES; LENTIVIRUS; MARMOTA MONAX; MURINAE; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS; WOODCHUCK HEPATITIS B VIRUS;

EID: 0036194454     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2002.0541     Document Type: Article

References (38)

1. Dendritic cells and the control of immunity
2. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
3. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
4. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
5. GM-CSF and TNF-α cooperative in the generation of dendritic Langerhans cells
6. Enhanced transgene expression in cord blood cd34(+)-derived hematopoietic cells, including developing T cells and nod/scid mouse repopulating cells, following transduction with modified trip lentiviral vectors
7. High-level transgene expression in human hematopoietic progenitors and differentiated blood lineages after transduction with improved lentiviral vectors
8. Development of minimal lentivirus vectors derived from simian immunodeficiency virus (SIVmac251) and their use for gene transfer into human dendritic cells
9. Postentry restriction to human immunodeficiency virus-based vector transduction in human monocytes
10. Efficient gene transfer to human peripheral blood monocyte-derived dendritic cells using human immunodeficiency virus type 1-based lentiviral vectors
11. Lentivirus-transduced human monocyte-derived dendritic cells efficiently stimulate antigen-specific cytotoxic T lymphocytes
12. HIV-1 genome nuclear import is mediated by a central DNA flap
13. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
14. Development of a self-inactivating lentivirus vector
15. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
16. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
17. Characterization of novel lentiviral vectors derived from simian immunodeficiency virus that efficiently transduce mature dendritic cells
18. Sequence-specific RNA binding by the HIV-1 Rev protein
19. Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: A dual function for an arginine-rich binding motif
20. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs
21. A functional interaction between Rev and yeast pre-mRNA is related to splicing complex formation
22. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing
23. Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs
24. Control of human immunodeficiency virus type 1 RNA metabolism: Role of splice sites and intron sequences in unspliced viral RNA subcellular distribution
25. Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases
26. Identification of positive and negative splicing regulatory elements within the terminal tat-rev exon of human immunodeficiency virus type 1
27. The cardiac troponin T alternative exon contains a novel purine-rich positive splicing element
28. The vpx gene of simian immunodeficiency virus facilitates efficient viral replication in fresh lymphocytes and macrophage
29. Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM)
30. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells
31. The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells
32. Functional analysis of the simian immunodeficiency virus Vpx protein: Identification of packaging determinants and a novel nuclear targeting domain
33. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses
34. Viral vectors for dendritic cell-based immunotherapy
35. A new-generation stable inducible packaging cell line for lentiviral vectors
36. A stable system for the high-titer production of multiply attenuated lentiviral vectors
37. An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins
38. Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors